QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
Log in
LON:AGY

Allergy Therapeutics plc (AGY.L) Share Forecast, Price & News

GBX 19.70
+0.25 (+1.29 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
19
Now: GBX 19.70
19.74
50-Day Range
14.55
MA: GBX 16.98
21.75
52-Week Range
7
Now: GBX 19.70
22
Volume280,277 shs
Average Volume650,183 shs
Market Capitalization£126.24 million
P/E Ratio17.91
Dividend YieldN/A
BetaN/A
Allergy Therapeutics plc engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Acarovac MPL, Venomil, Synbiotics, Penicillin Diagnostics, and Peanut. The company also develops allergy vaccines for grass, tree, and house dust mite, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
Allergy Therapeutics plc (AGY.L) logo

MarketRank

Overall MarketRank

1.22 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1903-844700
Employees600
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£78.20 million
Cash FlowGBX 5.74 per share
Book ValueGBX 6.90 per share

Profitability

Miscellaneous

Market Cap£126.24 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 19.70
+0.25 (+1.29 %)
(As of 01/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AGY News and Ratings via Email

Sign-up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Allergy Therapeutics plc (AGY.L) (LON:AGY) Frequently Asked Questions

How has Allergy Therapeutics plc (AGY.L)'s stock price been impacted by COVID-19 (Coronavirus)?

Allergy Therapeutics plc (AGY.L)'s stock was trading at GBX 9.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AGY shares have increased by 113.0% and is now trading at GBX 19.70.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Allergy Therapeutics plc (AGY.L)?

Wall Street analysts have given Allergy Therapeutics plc (AGY.L) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Allergy Therapeutics plc (AGY.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Allergy Therapeutics plc (AGY.L)'s earnings last quarter?

Allergy Therapeutics plc (AGY.L) (LON:AGY) announced its earnings results on Wednesday, March, 4th. The company reported $2.40 earnings per share (EPS) for the quarter.
View Allergy Therapeutics plc (AGY.L)'s earnings history
.

Who are some of Allergy Therapeutics plc (AGY.L)'s key competitors?

What other stocks do shareholders of Allergy Therapeutics plc (AGY.L) own?

Who are Allergy Therapeutics plc (AGY.L)'s key executives?

Allergy Therapeutics plc (AGY.L)'s management team includes the following people:
  • Mr. Manuel Llobet, CEO & Exec. Director (Age 56, Pay $496.46k)
  • Mr. Nicolas Alexander Ulrich Wykeman, CFO & Exec. Director (Age 55, Pay $284.83k)
  • Ms. Beverly Lees, Group Operations Director
  • Dr. Murray Skinner, Chief Scientific Officer
  • Mr. Santiago Puig, Bus. Devel. Director
  • Ms. Sue Baker, Head of HR
  • Simon Piggott, Head of Clinical Science
  • Alan Bullimore, Head of Communication & Market Devel.
  • Mr. Russell Picket, Group Financial Controller
  • Sara Goldsbrough, Company Sec.

What is Allergy Therapeutics plc (AGY.L)'s stock symbol?

Allergy Therapeutics plc (AGY.L) trades on the London Stock Exchange (LON) under the ticker symbol "AGY."

How do I buy shares of Allergy Therapeutics plc (AGY.L)?

Shares of AGY and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Allergy Therapeutics plc (AGY.L)'s stock price today?

One share of AGY stock can currently be purchased for approximately GBX 19.70.

How big of a company is Allergy Therapeutics plc (AGY.L)?

Allergy Therapeutics plc (AGY.L) has a market capitalization of £126.24 million and generates £78.20 million in revenue each year. Allergy Therapeutics plc (AGY.L) employs 600 workers across the globe.

What is Allergy Therapeutics plc (AGY.L)'s official website?

The official website for Allergy Therapeutics plc (AGY.L) is www.allergytherapeutics.com.

How can I contact Allergy Therapeutics plc (AGY.L)?

Allergy Therapeutics plc (AGY.L)'s mailing address is Dominion Way, WORTHING, BN14 8SA, United Kingdom. The company can be reached via phone at +44-1903-844700.

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.